Navigation Links
VIVUS Announces Abstract Published at American Diabetes Association,Scientific Sessions

actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; uncertainties of patent protection and litigation; uncertainties of government or third party payer reimbursement; reliance on sole source suppliers; limited sales and marketing efforts and dependence upon third parties; risks related to the development of innovative products; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any pharmaceutical under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that the EvaMist NDA submission will be approved in a timely basis, or at all. There are no guarantees that future clinical studies discussed in this press release will be completed or successful or that any product will receive regulatory approval for any indication or prove to be commercially successful. VIVUS does not undertake an obligation to update or revise any forward-looking statement. Investors should read the risk factors set forth in VIVUS' Form 10- K for the year ended December 31, 2006 and periodic reports filed with the Securities and Exchange Commission.

Contact

VIVUS, Inc.
Timothy E. Morris, 650-934-5200
Chief Financial Officer
or
The Trout Group
Ian Clements (SF), 415-392-3385
Brian Korb (NYC), 646-378-2923


'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/12/2014)... -- Royal Philips (NYSE: PHG AEX: PHIA) ... 56th Annual Meeting in San Francisco ... consistency and accuracy in cancer treatment. Producing quality results ... oncology solutions underscore Philips, dedication to leading healthcare into ... "Philips is leveraging our expertise in CT, ...
(Date:9/12/2014)... MARIETTA, Ga. , Sept. 12, 2014  WellStar ... Georgia and became the second in the ... sleep apnea.  As part of WellStar Health System, Paulding ... continually offering the latest treatments and solutions. ... sleep apnea in patients who are unable to use ...
(Date:9/12/2014)... According to the new research ... Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by ... & Prescription Based - Global Forecast to 2018" published ... over the forecast period of 2013 to 2018. The ... 9.3% from 2013 to 2018, to reach $27.5 billion ...
Breaking Medicine Technology:Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 2Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 3WellStar Pioneers New Sleep Apnea Treatment 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 3Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 4
... May 16, 2011 /PRNewswire-Asia/ -- Global Pharm Holdings ... "Company"), a China-based leading vertically integrated pharmaceutical company ... cultivation businesses through its subsidiaries in the Anhui, ... financial results for the first quarter ended March ...
... MAYWOOD, N.J., May 16, 2011 New Jersey Center ... sites in the nation to treat advanced prostate cancer ... therapeutic class known as autologous cellular immunotherapies.  PROVENGE was ... for the treatment of men with asymptomatic or minimally ...
Cached Medicine Technology:Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 2Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 3Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 4Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 5Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 6Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 7Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 8Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 9Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 10Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 11New Jersey Center for Prostate Cancer & Urology Among First in Nation to Treat Advanced Prostate Cancer Patients with PROVENGE 2
(Date:9/14/2014)... 14, 2014 UWDress.com, is an internationally ... has recently announced its new range of cocktail ... bring more benefits to worldwide ladies, the company is ... lace wedding outfits, blue evening gowns, black formal gowns ... 70 percent off. , The company’s senior spokesman ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 East ... a renowned Vancouver chiropractic clinic, has recently published ... In this latest blog on the topic, Dr ... clarified several myths that people have regarding this ... between the services of a chiropractor and that ...
(Date:9/13/2014)... -- Researchers say they,ve tracked specific activity in the ... clear whether imagination and memory were distinct processes, so ... decided to explore the issue. "I was thinking ... imagining myself in the future, and I started wondering ... Ashby said in a university news release. "I ...
(Date:9/13/2014)... Top10BestSEOHosting.com is a well-known review website the ... web hosting suppliers and announced that FatCow ( ... ASP.NET hosting suppliers in 2014. According to the ... very popular way for webmasters to build dynamic ... is happy to introduce Arvixe, FatCow.com, and Hostgator ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 New York is ... declaring September 23, 2014, Falls Prevention Awareness Day. , ... injuries for those 65 years of age and over. Every ... department for a fall-related injury. Every day because of a ... New Yorkers are hospitalized; and two New Yorkers die. The ...
Breaking Medicine News(10 mins):Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2Health News:East Vancouver Chiropractor Releases Blog to Bust Myths about Chiropractic Medicine 2Health News:Scientists Watch Imagination at Work in the Brain 2Health News:Best ASP.NET Hosting Suppliers in 2014 Unveiled By Top10BestSEOHosting.com 2Health News:The New York Physical Therapy Association Supports a Strong Today – Falls Free® Tomorrow on Falls Prevention Awareness Day 2Health News:The New York Physical Therapy Association Supports a Strong Today – Falls Free® Tomorrow on Falls Prevention Awareness Day 3Health News:The New York Physical Therapy Association Supports a Strong Today – Falls Free® Tomorrow on Falls Prevention Awareness Day 4
... BEDFORD, Mass., Sept. 2 Hologic, Inc. (Nasdaq: HOLX ... at the 2009 Morgan Stanley Global Healthcare Unplugged Conference in New ... , , Interested parties are invited to ... the investor section of the company,s website at www.hologic.com/investor ...
... not create ,safety concern, agency says , WEDNESDAY, Sept. 2 ... many lipsticks are higher than those reported in 2007 by ... new analysis, conducted by the U.S. Food and Drug Administration ... of Cosmetic Science , used new techniques to determine the ...
... , , , ... the American Veterinary Medical Association (AVMA), was named chief executive officer ... to highlight the connections between human, animal, and environmental health. , ... group,s first board of directors meeting on August 14 in Washington, ...
... PHILADELPHIA (September 2, 2009) The Fox Chase Cancer ... National Center for Research Resources of the National Institutes ... facility. The new facility will support advanced ... the way for the development of new treatments. The ...
... space, may be the stuff dreams are made of. ... in those clouds, and it,s not dreams butmothballs? ... Georgia have just shown for the first time that ... as the Unidentified Infrared Bands (UIRs) is a gaseous ...
... Post study, approximately 20% of U.S. soldiers returning from ... a substantial number with post-traumatic stress disorder (PTSD), and ... become unacceptable to Army commanders and the soldiers, families. ... however, doctors will now be able to forecast a ...
Cached Medicine News:Health News:Lead Levels in Many Lipsticks Higher Than Reported 2Health News:Lead Levels in Many Lipsticks Higher Than Reported 3Health News:Former AVMA President to Head National Health Commission 2Health News:Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility 2Health News:University of Georgia researchers show component of mothballs is present in deep-space clouds 2Health News:University of Georgia researchers show component of mothballs is present in deep-space clouds 3Health News:Keeping the suicidal soldier alive 2
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
... PxE Thermal Cycler (PxE) is a licensed 96 ... features for value for money thermal cycling. ... sixteen years experience in manufacturing and retains a ... synonymous with other products in the range. ...
Custom programming of 3 hot blocks and 1 cold block, 30% reduction in cycling time, Unmatched well-to-well uniformity, No gradient feature...
... With Exceptional Performance The sleek ... might be the first things ... is designed for performance. With ... premium, its small footprint is ...
Medicine Products: